Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Although the reported clinical observations are known adverse events, no conclusion can be made.The valve location was in the pulmonary position, however there was a report of aortic insufficiency.As this device was not returned for evaluation, a failure mechanism was not able to be determined.
|
Medtronic received information that 59 months post implant of this transcatheter pulmonary valve, there were observations of valve occlusion, severe right ventricular dysfunction, severe aortic regurgitation, and left ventricle dilatation.Subsequently, the valve was explanted and replaced with another device.No subsequent adverse patient effects were reported.
|